Trazodone for Insomnia: Worth the Risk?

Published Online: Monday, May 1, 2006

The antidepressant trazodone is currently the second most commonly prescribed treatment for insomnia because of its sedative properties, perceived lack of risk, generic availability, and lack of duration-of-use restrictions. Whereas trazodone is not approved to treat insomnia, relatively few studies actually support its efficacy and safety.

A literature review of clinical trial data concerning trazodone, reported in the Journal of Clinical Psychiatry (April 2005), confirmed the lack of evidence for its effectiveness as an insomnia therapy.A high rate of discontinuation due to adverse effects accompanied the use of trazodone, as did the potential for drug tolerance. The author concluded that risk/benefit considerations may not warrant trazodone use in nondepressed and/or elderly insomnia patients.

Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues